Osaic Holdings
MACK

Osaic Holdings’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Osaic Holdings’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-60
Closed – – 7143
2020
Q4 		$0 Hold
60
– – ﹤0.01% 6811
2020
Q3 		$0 Hold
60
– – ﹤0.01% 6628
2020
Q2 		$0 Hold
60
– – ﹤0.01% 6571
2020
Q1 		$0 Buy
+60
New +$176 ﹤0.01% 6318

Other funds holding MACK

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Osaic Holdings's MACK Position: Q1 2021 in Review

Osaic Holdings sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q1 2021, closing a stake of 60 shares.

Osaic Holdings first reported a position in MACK in Q1 2020 and held it in 4 quarters. The position peaked at $0 in Q4 2020. 45 funds tracked by Wall St. Rank hold MACK as of Q1 2021.

  • Osaic Holdings reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Osaic Holdings sold 60 Merrimack Pharmaceuticals, Inc. shares in Q1 2021.
  • Osaic Holdings first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2020 and held it in 4 quarters.
  • Osaic Holdings's Merrimack Pharmaceuticals, Inc. position peaked at $0 in Q4 2020.
  • 45 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q1 2021.

Based on Osaic Holdings's 13F filing for Q1 2021, filed 13 May 2021.